The Pennsylvania Superior Court has sent a Risperdal case that initially came to a $1.75 million verdict back to the trial court to determine whether there should be a new trial on punitive damages.

A three-judge Superior Court panel on Tuesday issued its ruling in Murray v. Janssen Pharmaceuticals, which was the third case to go to trial from the Risperdal mass tort program in Philadelphia. The case had initially come to a $1.75 million verdict, which was later reduced by the trial court to $680,000.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]